Literature DB >> 24508465

Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.

Jose Carlos P Ferreira1, Nicole Schreiber-Agus2, Suzanne M Carter3, Susan Klugman4, Anthony R Gregg5, Susan J Gross4.   

Abstract

Exciting developments in the fields of genetics and genomics have facilitated the identification of the etiological basis of many Mendelian disorders. Several of the methods used in gene discovery have focused initially on homogeneous populations, including the Ashkenazi Jewish population. The founder effect is well recognized in this community, in which historical events and cultural behaviors have resulted in a limited number of mutations underlying genetic disorders with substantial health impact. New technologies have made it possible to rapidly expand the test panels, changing testing paradigms, and thereby creating challenges for the physician in deciphering the appropriate approach to genetic screening in this population. The goal of this review is to help primary obstetric health care providers navigate through this quickly moving field so as to better counsel and support their patients of Ashkenazi Jewish heritage.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Ashkenazi Jewish; genetic screening; genomic medicine; preconception care; prenatal testing

Mesh:

Year:  2014        PMID: 24508465     DOI: 10.1016/j.ajog.2014.02.001

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Challenges of Pre- and Post-Test Counseling for Orthodox Jewish Individuals in the Premarital Phase.

Authors:  E Rose; N Schreiber-Agus; K Bajaj; S Klugman; T Goldwaser
Journal:  J Genet Couns       Date:  2015-09-10       Impact factor: 2.537

2.  Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Anthony R Gregg; Mahmoud Aarabi; Susan Klugman; Natalia T Leach; Michael T Bashford; Tamar Goldwaser; Emily Chen; Teresa N Sparks; Honey V Reddi; Aleksandar Rajkovic; Jeffrey S Dungan
Journal:  Genet Med       Date:  2021-07-20       Impact factor: 8.864

3.  Expanding preconception carrier screening for the Jewish population using high throughput microfluidics technology and next generation sequencing.

Authors:  Moran Gal; Khen Khermesh; Michal Barak; Min Lin; Hadas Lahat; Haike Reznik Wolf; Michael Lin; Elon Pras; Erez Y Levanon
Journal:  BMC Med Genomics       Date:  2016-05-13       Impact factor: 3.063

4.  Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?

Authors:  Kim C A Holtkamp; Merel C van Maarle; Maria J E Schouten; Wybo J Dondorp; Phillis Lakeman; Lidewij Henneman
Journal:  Eur J Hum Genet       Date:  2015-05-13       Impact factor: 4.246

5.  Factors for successful implementation of population-based expanded carrier screening: learning from existing initiatives.

Authors:  Kim C A Holtkamp; Inge B Mathijssen; Phillis Lakeman; Merel C van Maarle; Wybo J Dondorp; Lidewij Henneman; Martina C Cornel
Journal:  Eur J Public Health       Date:  2017-04-01       Impact factor: 3.367

Review 6.  Recent developments in genetic/genomic medicine.

Authors:  Rachel H Horton; Anneke M Lucassen
Journal:  Clin Sci (Lond)       Date:  2019-03-05       Impact factor: 6.124

7.  Tay-Sachs Carrier Screening by Enzyme and Molecular Analyses in the New York City Minority Population.

Authors:  Nikita Mehta; Gabriel A Lazarin; Erica Spiegel; Kathleen Berentsen; Kelly Brennan; Jessica Giordano; Imran S Haque; Ronald Wapner
Journal:  Genet Test Mol Biomarkers       Date:  2016-06-30

8.  'We are all in the image of God': reproductive imaginaries and prenatal genetic testing in American Jewish communities.

Authors:  Faye Ginsburg; Rayna Rapp
Journal:  Reprod Biomed Soc Online       Date:  2020-07-06

9.  Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients.

Authors:  Gidon Akler; Ashley H Birch; Nicole Schreiber-Agus; Xiaoqiang Cai; Guiqing Cai; Lisong Shi; Chunli Yu; Anastasia M Larmore; Geetu Mendiratta-Vij; Lama Elkhoury; Mitchell W Dillon; Jun Zhu; Andrew S Mclellan; Funda E Suer; Bryn D Webb; Eric E Schadt; Ruth Kornreich; Lisa Edelmann
Journal:  Mol Genet Genomic Med       Date:  2019-12-27       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.